JP2009502797A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502797A5
JP2009502797A5 JP2008522911A JP2008522911A JP2009502797A5 JP 2009502797 A5 JP2009502797 A5 JP 2009502797A5 JP 2008522911 A JP2008522911 A JP 2008522911A JP 2008522911 A JP2008522911 A JP 2008522911A JP 2009502797 A5 JP2009502797 A5 JP 2009502797A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
isolated peptide
group
cupredoxin
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008522911A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009502797A (ja
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Priority claimed from US11/436,592 external-priority patent/US7381701B2/en
Application filed filed Critical
Priority claimed from PCT/US2006/027940 external-priority patent/WO2007024368A2/en
Publication of JP2009502797A publication Critical patent/JP2009502797A/ja
Publication of JP2009502797A5 publication Critical patent/JP2009502797A5/ja
Pending legal-status Critical Current

Links

JP2008522911A 2005-07-19 2006-07-19 血管形成をキュプレドキシンで制御するための組成物および方法 Pending JP2009502797A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70029705P 2005-07-19 2005-07-19
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US76474906P 2006-02-03 2006-02-03
US11/436,592 US7381701B2 (en) 2001-02-15 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
PCT/US2006/027940 WO2007024368A2 (en) 2005-07-19 2006-07-19 Compositions and methods to control angiogenesis with cupredoxins

Publications (2)

Publication Number Publication Date
JP2009502797A JP2009502797A (ja) 2009-01-29
JP2009502797A5 true JP2009502797A5 (cg-RX-API-DMAC7.html) 2009-09-10

Family

ID=37772089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008522911A Pending JP2009502797A (ja) 2005-07-19 2006-07-19 血管形成をキュプレドキシンで制御するための組成物および方法

Country Status (10)

Country Link
EP (1) EP1904081A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009502797A (cg-RX-API-DMAC7.html)
KR (1) KR20080034905A (cg-RX-API-DMAC7.html)
AU (1) AU2006284490A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0615555A2 (cg-RX-API-DMAC7.html)
CA (1) CA2615560A1 (cg-RX-API-DMAC7.html)
IL (1) IL188691A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008000993A (cg-RX-API-DMAC7.html)
NO (1) NO20080829L (cg-RX-API-DMAC7.html)
WO (1) WO2007024368A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158574B2 (en) * 2004-10-07 2012-04-17 Cdg Therapeutics, Inc. Compositions and methods to prevent cancer with cupredoxins
EP2061498A4 (en) * 2006-09-14 2009-11-04 Univ Illinois COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
UA97466C2 (ru) * 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
JP2008545398A (ja) * 2005-05-20 2008-12-18 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法
AU2006251742A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating malaria with cupredoxin and cytochrome

Similar Documents

Publication Publication Date Title
CA3231953A1 (en) Compositions and methods for the treatment of metabolic and liver disorders
TWI282282B (en) Method for treating pain by peripheral administration of a neurotoxin
RU2009113812A (ru) Композиции и способы для профилактики рака с помощью купредоксинов
CN109379888B (zh) 包含带有羧酸根电荷和疏水性基团的共聚氨基酸的可注射溶液
RU2009125599A (ru) Композиции и способы лечения рака cpg-богатой днк и купредоксинами
JP2010503409A5 (cg-RX-API-DMAC7.html)
JP2006501820A5 (cg-RX-API-DMAC7.html)
JP2018123169A (ja) ヘプシジン類似体及びその使用
RU2009133473A (ru) Композиции и способы для предотвращения рака с помощью купредоксинов
JP6738739B2 (ja) 膀胱内滴下注入用生物製剤
CN108472329B (zh) 多肽刺激免疫系统的用途
EA039105B1 (ru) Катионные нейротоксины
GB2327675A (en) Nicotinic acid amide derivatives
JP2008535805A5 (cg-RX-API-DMAC7.html)
CN117298254A (zh) 用于口服递送生物活性货物的cholix毒素衍生的融合分子
ZA200300313B (en) Chemokine receptor modulators, production and use.
CA3221611A1 (en) Long-acting dual gip/glp-1 peptide conjugates and methods of use
CA2795168A1 (en) Factor xii inhibitors for treating interstitial lung disease
BR112013006088B1 (pt) Construto de entrega isolado, e, composição farmacêutica
CN103372199A (zh) 一种预防和治疗神经退行性疾病的新型脑部靶向制剂
BRPI0810384B1 (pt) terapia enzimática anticâncer
JP2015500823A (ja) Glp−1アゴニスト
TW202140074A (zh) Fgf-21結合物調配物
CN102149725A (zh) 用于抑制g2细胞周期停滞和使细胞对dna损伤剂敏感的cbp501衍生制剂及基于其的方法
US20130035294A1 (en) Neuromedin and FN-38 Peptides for Psychotic Diseases